Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-06T01:19:12.623Z Has data issue: false hasContentIssue false
  • English
  • Français

A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment

Published online by Cambridge University Press:  13 September 2016

Vincent C. C. Cheng ,
Jonathan H. K. Chen ,
Simon Y. C. So ,
Sally C. Y. Wong ,
Pui-Hing Chau ,
Lisa M. W. Wong ,
Radley H. C. Ching ,
Modissa M. L. Ng ,
Wan-Mui Lee  and
Ivan F. N. Hung
...Show all authors
Vincent C. C. Cheng
Affiliation:
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Jonathan H. K. Chen
Affiliation:
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Simon Y. C. So
Affiliation:
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Sally C. Y. Wong
Affiliation:
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Pui-Hing Chau
Affiliation:
School of Nursing, The University of Hong Kong, Hong Kong Special Administrative Region, China
Lisa M. W. Wong
Affiliation:
Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Radley H. C. Ching
Affiliation:
Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Modissa M. L. Ng
Affiliation:
Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Wan-Mui Lee
Affiliation:
Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Ivan F. N. Hung
Affiliation:
Department of Medicine, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Pak-Leung Ho
Affiliation:
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Kwok-Yung Yuen*
Affiliation:
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China
*
Address correspondence to Kwok-Yung Yuen, State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region, China ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

To study the association between gastrointestinal colonization of carbapenemase-producing Enterobacteriaceae (CPE) and proton pump inhibitors (PPIs).

METHODS

We analyzed 31,526 patients with prospective collection of fecal specimens for CPE screening: upon admission (targeted screening) and during hospitalization (opportunistic screening, safety net screening, and extensive contact tracing), in our healthcare network with 3,200 beds from July 1, 2011, through December 31, 2015. Specimens were collected at least once weekly during hospitalization for CPE carriers and subjected to broth enrichment culture and multiplex polymerase chain reaction.

RESULTS

Of 66,672 fecal specimens collected, 345 specimens (0.5%) from 100 patients (0.3%) had CPE. The number and prevalence (per 100,000 patient-days) of CPE increased from 2 (0.3) in 2012 to 63 (8.0) in 2015 (P<.001). Male sex (odds ratio, 1.91 [95% CI, 1.15–3.18], P=.013), presence of wound or drain (3.12 [1.70–5.71], P<.001), and use of cephalosporins (3.06 [1.42–6.59], P=.004), carbapenems (2.21 [1.10–4.48], P=.027), and PPIs (2.84 [1.72–4.71], P<.001) in the preceding 6 months were significant risk factors by multivariable analysis. Of 79 patients with serial fecal specimens, spontaneous clearance of CPE was noted in 57 (72.2%), with a median (range) of 30 (3–411) days. Comparing patients without use of antibiotics and PPIs, consumption of both antibiotics and PPIs after CPE identification was associated with later clearance of CPE (hazard ratio, 0.35 [95% CI, 0.17–0.73], P=.005).

CONCLUSIONS

Concomitant use of antibiotics and PPIs prolonged duration of gastrointestinal colonization by CPE.

Infect Control Hosp Epidemiol 2016;1418–1425

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 12 , December 2016 , pp. 1418 - 1425
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Tzouvelekis, LS, Markogiannakis, A, Psichogiou, M, Tassios, PT, Daikos, GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012;25:682–707.Google Scholar
2. Villegas, MV, Pallares, CJ, Escandon-Vargas, K, et al. Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing Enterobacteriaceae in seven Latin American countries. PLOS ONE 2016;11:e0154092.Google Scholar
3. Won, SY, Munoz-Price, LS, Lolans, K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53:532–540.Google Scholar
4. Morris, D, Boyle, F, Morris, C, et al. Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother 2012;67:2367–2372.Google Scholar
5. Weterings, V, Zhou, K, Rossen, JW, et al. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis 2015;34:1647–1655.CrossRefGoogle ScholarPubMed
6. Delory, T, Seringe, E, Antoniotti, G, et al. Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management. Am J Infect Control 2015;43:1070–1075.Google Scholar
7. Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848–855.CrossRefGoogle Scholar
8. Hayden, MK, Lin, MY, Lolans, K, et al. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis 2015;60:1153–1161.Google Scholar
9. Johnson, AP, Woodford, N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62:499–513.Google Scholar
10. Ho, PL, Li, Z, Lai, EL, Chiu, SS, Cheng, VC. Emergence of NDM-1-producing Enterobacteriaceae in China. J Antimicrob Chemother 2012;67:1553–1555.Google Scholar
11. Cheng, VC, Chan, JF, Wong, SC, et al. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J (Engl) 2013;126:4504–4509.Google Scholar
12. Rossini, A, Di Santo, SG, Libori, MF, Tiracchia, V, Balice, MP, Salvia, A. Risk factors for carbapenemase-producing Enterobacteriaceae colonization of asymptomatic carriers on admission to an Italian rehabilitation hospital. J Hosp Infect 2016;92:78–81.CrossRefGoogle Scholar
13. Cheng, VC, Tai, JW, Chen, JH, et al. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc 2014;113:734–741.Google Scholar
14. Cheng, VC, Chen, JH, So, SY, et al. Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii . Eur J Clin Microbiol Infect Dis 2015;34:2359–2366.Google Scholar
15. Cheng, VC, Chen, JH, Poon, RW, et al. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene. Eur J Clin Microbiol Infect Dis 2015;34:713–718.Google Scholar
16. Cheng, VC, Tai, JW, Wong, LM, et al. Effect of proactive infection control measures on benchmarked rate of hospital outbreaks: an analysis of public hospitals in Hong Kong over 5 years. Am J Infect Control 2015;43:965–970.Google Scholar
17. Cheng, VC, Tai, JW, Li, WS, et al. Implementation of directly observed patient hand hygiene for hospitalized patients by hand hygiene ambassadors in Hong Kong. Am J Infect Control 2016;44:621–624.CrossRefGoogle ScholarPubMed
18. Cheng, VC, Chau, PH, Lee, WM, et al. Hand-touch contact assessment of high-touch and mutual-touch surfaces among healthcare workers, patients, and visitors. J Hosp Infect 2015;90:220–225.Google Scholar
19. Ho, PL, Cheung, YY, Wang, Y, et al. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong. Eur J Clin Microbiol Infect Dis 2016;35:379–385.Google Scholar
20. Cheng, VC, Chen, JH, Wong, SC, Ho, PL, Yuen, KY. Gastrointestinal colonization with multiple New Delhi metallo-beta-lactamase-producing Enterobacteriaceae isolates in the same patient: a potential challenge in outbreak investigation. J Hosp Infect 2016;92:108–109.CrossRefGoogle Scholar
21. Swaminathan, M, Sharma, S, Poliansky Blash, S, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013;34:809–817.Google Scholar
22. Zhao, ZC, Xu, XH, Liu, MB, Wu, J, Lin, J, Li, B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control 2014;42:e61–e64.Google Scholar
23. Ben-David, D, Masarwa, S, Navon-Venezia, S, et al. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 2011;32:845–853.Google Scholar
24. Yang, J, Ye, L, Guo, L, et al. A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect 2013;19:E509–E515.CrossRefGoogle Scholar
25. Zheng, R, Zhang, Q, Guo, Y, et al. Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China. Ann Clin Microbiol Antimicrob 2016;15:10.Google Scholar
26. Cheng, VC, Tai, JW, Ng, ML, et al. Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. Chin Med J (Engl) 2012;125:3450–3457.Google Scholar
27. Guerra, B, Fischer, J, Helmuth, R. An emerging public health problem: acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. Vet Microbiol 2014;171:290–297.Google Scholar
28. Morrison, BJ, Rubin, JE. Carbapenemase producing bacteria in the food supply escaping detection. PLoS One 2015;10:e0126717.CrossRefGoogle ScholarPubMed
29. Cheng, VC, Wong, SC, Ho, PL, Yuen, KY. Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China. Emerg Microbes Infect 2015;4:e8.Google Scholar
30. Cheng, VC, Li, IW, Wu, AK, et al. Effect of antibiotics on the bacterial load of meticillin-resistant Staphylococcus aureus colonisation in anterior nares. J Hosp Infect 2008;70:27–34.Google Scholar
31. Papadimitriou-Olivgeris, M, Marangos, M, Fligou, F, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012;67:2976–2981.Google Scholar
32. Gagliotti, C, Giordani, S, Ciccarese, V, et al. Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study. Am J Infect Control 2014;42:1006–1008.CrossRefGoogle ScholarPubMed
33. Lubbert, C, Lippmann, N, Busch, T, et al. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany. Am J Infect Control 2014;42:376–380.Google Scholar
34. Jackson, MA, Goodrich, JK, Maxan, ME, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 2016;65:749–756.Google Scholar
35. Dang, TT, Majumdar, SR, Marrie, TJ, Eurich, DT. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients. Drugs Aging 2015;32:13–19.Google Scholar
36. Janarthanan, S, Ditah, I, Adler, DG, Ehrinpreis, MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012;107:1001–1010.Google Scholar
37. Kwok, CS, Arthur, AK, Anibueze, CI, Singh, S, Cavallazzi, R, Loke, YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012;107:1011–1019.Google Scholar
38. Corleto, VD, Festa, S, Di Giulio, E, Annibale, B. Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes 2014;21:3–8.Google Scholar
39. Fung, IC, Cairncross, S. How often do you wash your hands? A review of studies of hand-washing practices in the community during and after the SARS outbreak in 2003. Int J Environ Health Res 2007;17:161–183.Google Scholar